In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2802-2804

  Klugman, Keith P ^a,c   Capper, Thora ^a   Bryskier, Andre ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SANOFI   (France)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; LEVOFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029838018     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2802     Document Type: Article

References (18)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Cormican, M. G., and R. N. Jones. 1995. Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin. J. Clin. Microbiol. 33:215-216.
3. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams and Wilkins, Baltimore.
4. Friedland, I. R., and G. J. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
5. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
6. Giron, K. P., M. E. Gross, D. M. Musher, T. W. Williams, Jr., and R. A. Tharappel. 1995. In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or l-ofloxacin. Antimicrob. Agents Chemother. 39:2798-2800.
7. Goldstein, F. W., P. Geslin, J. F. Acar, and French Study Group. 1994. Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 13:33-34.
8. Janoir, C., V. Zeller, M. D. Kitzis, and L. Gutmann. 1996. GyrA mutations in in-vitro selected and clinical fluoroquinolone (FQ)-resistant strains of Streptococcus pneumoniae (SPn), abstr. C2, p. 34. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Jimenez, J. M., and A. Peris. 1990. Therapeutic failure and selection for resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 9:905-906.
10. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
11. Klugman, K. P. 1994. Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci. Eur. J. Clin. Microbiol. Infect. Dis. 13:5-7.
12. 11a. Klugman, K. P., and T. Capper. 1995. Levofloxacin in vitro activity and synergistic activity in combination with other antimicrobials against antibiotic-resistant S. pneumoniae, and selection of resistant mutants, abstr. E9. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Klugman, K. P., I. R. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
14. Lafredo, S. C., B. D. Foleno, and K. P. Fu. 1993. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro. Chemotherapy (Basel) 39:36-39.
15. Linares, J., F. Tubau, R. Pallares, C. Ardanuv, R. Martin, R. Muñoz, and A. G. Campa. 1996. Streptococcus pneumoniae (Spn): susceptibility to fluoroquinolones (FQ), abstr. C3, p. 34. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing. M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Nau, R., T. Schmidt, K. Kaye, J. L. Froula, and M. G. Tauber. 1995. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 39:593-597.
18. Onodera, Y., M. Tanaka, K. Sato, and I. Hayakawa. 1996. Molecular cloning of Streptococcus pneumoniae DNA topoisomerase IV, abstr. C4, p. 34. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.